Tal Zvi Zaks, Chief Medical Officer at Moderna, Inc. (MRNA), sold 6,666 shares at $122.72 ($827K) on 2021-01-19, disclosed to the SEC on 2021-01-20.
Open-market sale of $827k MRNA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $121.59 | 334 | $41K | 4.9% |
| 2 | $122.72 | 1,300 | $160K | 19.3% |
| 3 | $123.57 | 1,000 | $124K | 14.9% |
| 4 | $124.72 | 1,666 | $208K | 25.1% |
| 5 | $124.72 | 1,666 | $208K | 25.1% |
| 6 | $125.57 | 700 |
| $88K |
| 10.6% |
| Total | $124.09 avg | 6,666 | $827K | 100% |
| Filing → |
| MRNA | SELL | 2021-06-25 | $1.1M | — | Filing → |
| MRNA | SELL | 2021-06-21 | $1.0M | — | Filing → |
| MRNA | SELL | 2021-06-11 | $1.1M | — | Filing → |